| Date Filed | Type | Description |
| 08/23/2023 |
4
| Gano Kyle (Chief Business Development Off) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 2,132 shares
@ $107.4075, valued at
$229k
|
|
| 02/08/2023 |
4
| Gano Kyle (Chief Business Development Off) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 1,600 shares
@ $105.6422, valued at
$169k
Sold 1,623 shares
@ $102.2884, valued at
$166k
Sold 12,801 shares
@ $102.4114, valued at
$1.3M
Sold 980 shares
@ $103.9898, valued at
$101.9k
|
|
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2022 |
4
| Gano Kyle (Chief Business Development Off) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 703 shares
@ $80.683, valued at
$56.7k
Sold 1,974 shares
@ $80.8002, valued at
$159.5k
Sold 1,623 shares
@ $80.7791, valued at
$131.1k
Sold 1,600 shares
@ $80.7656, valued at
$129.2k
Sold 980 shares
@ $79.672, valued at
$78.1k
|
|
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/07/2022 |
4
| Gano Kyle (Chief Business Development Off) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 28,266 shares
@ $85.5003, valued at
$2.4M
Exercised 28,266 options to buy
@ $8.66, valued at
$244.8k
|
|
| 03/29/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 02/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/16/2020 |
4
| Gano Kyle (Chief Business Development Off) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 2,257 shares
@ $90.7268, valued at
$204.8k
|
|
| 08/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/28/2020 |
4
| Gano Kyle (Chief Business Development Off) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 1,934 shares
@ $99.4709, valued at
$192.4k
|
|
| 02/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2020 |
4
| Gano Kyle (Chief Business Development Off) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 1,013 shares
@ $103.0072, valued at
$104.3k
Sold 703 shares
@ $103.0347, valued at
$72.4k
Sold 1,974 shares
@ $103.0812, valued at
$203.5k
Sold 1,000 shares
@ $101.413, valued at
$101.4k
Granted 76,683 options
@ $102.9, valued at
$7.9M
Granted 12,148 restricted stock units
@ $0 |
|
| 02/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/06/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/03/2018 |
4
| Gano Kyle (Chief Business Development Off) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 28,266 shares
@ $115, valued at
$3.3M
Exercised 28,266 options to buy
@ $8.66, valued at
$244.8k
|
|
| 03/07/2018 |
4
| Gano Kyle (Chief Business Development Off) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 23,650 shares
@ $90, valued at
$2.1M
Exercised 23,650 options to buy
@ $8.65, valued at
$204.6k
|
|
| 02/07/2018 |
4
| Gano Kyle (Chief Business Development Off) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 1,375 shares
@ $82.9784, valued at
$114.1k
Sold 671 shares
@ $83.1872, valued at
$55.8k
Paid exercise price by delivering 658 shares
@ $82.48, valued at
$54.3k
Granted 30,400 options
@ $81.49, valued at
$2.5M
Granted 5,350 restricted stock units
@ $0
Granted 12,250 restricted stock units
@ $0
Granted 15,000 restricted stock units
@ $0 |
|
| 01/18/2018 |
4
| Gano Kyle (Chief Business Development Off) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 1,625 shares
@ $79.052, valued at
$128.5k
|
|
| 11/06/2017 |
4
| Gano Kyle (Chief Business Development Off) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 11,350 shares
@ $71.05, valued at
$806.4k
Sold 13,468 shares
@ $71.05, valued at
$956.9k
Exercised 11,350 options to buy
@ $8.65, valued at
$98.2k
Exercised 13,468 options to buy
@ $8.66, valued at
$116.6k
|
|
| 10/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/13/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/12/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/13/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/04/2016 |
4
| Gano Kyle (Chief Business Development Off) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 1,375 shares
@ $37.98, valued at
$52.2k
|
|
| 09/05/2013 |
4
| Gano Kyle (Chief Business Dev Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 2,400 shares
@ $15.61, valued at
$37.5k
Sold 2,400 shares
@ $15.61, valued at
$37.5k
Exercised (in-or-at-the-money) 2,400 options to buy
@ $10.9, valued at
$26.2k
Exercised (in-or-at-the-money) 2,400 options to buy
@ $10.9, valued at
$26.2k
|
|